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BACKGROUND: Atypical Myeloproliferative Neoplasms (aMPN) share characteristics
of MPN and Myelodysplastic Syndromes. Although abnormalities in cytokine signaling
are common in MPN, the pathophysiology of atypical MPN still remains elusive. Since
deregulation of microRNAs is involved in the biology of various cancers, we studied
the miRNome of aMPN patients.
METHODS: MiRNome and mutations in epigenetic regulator genes ASXL1, TET2,
DNMT3A, EZH2 and IDH1/2 were explored in aMPN patients. Epigenetic regulation
of miR-10a and HOXB4 expression was investigated by treating hematopoietic cell
lines with 5-aza-2'deoxycytidine, valproic acid and retinoic acid. Functional effects of
miR-10a overexpression on cell proliferation, differentiation and self-renewal were
studied by transducing CD34 cells with lentiviral vectors encoding the pri-miR-10a
precursor.
RESULTS: MiR-10a was identified as the most significantly up-regulated microRNA in
aMPN. MiR-10a expression correlated with that of HOXB4, sitting in the same
genomic locus. The transcription of these two genes was increased by DNA
demethylation and histone acetylation, both necessary for optimal expression
induction by retinoic acid. Moreover, miR-10a and HOXB4 overexpression seemed
associated with DNMT3A mutation in hematological malignancies. However,
overexpression of miR-10a had no effect on proliferation, differentiation or self-
renewal of normal hematopoietic progenitors.
CONCLUSIONS: MiR-10a and HOXB4 are overexpressed in aMPN. This
overexpression seems to be the result of abnormalities in epigenetic regulation
mechanisms. Our data suggest that miR-10a could represent a simple marker of
transcription at this genomic locus including HOXB4, widely recognized as involved in
stem cell expansion.
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